Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR InterplayChen et al. This evidence concerns the gene NLRP3 and diabetic cardiomyopathy.